100 results
424B5
LYEL
Lyell Immunopharma, Inc.
6 May 24
Prospectus supplement for primary offering
8:12am
to such agreement, including, in some cases, for the purpose of allocating risk among the parties to such agreements, and should not be deemed … .
Because we have not designated the amount of net proceeds from this offering to be used for any particular purpose, our management will have broad
S-3
EX-1.2
LYEL
Lyell Immunopharma, Inc.
28 Feb 24
Shelf registration
7:49pm
or any Rule 462(b) Registration Statement is in effect and no proceedings for such purpose have been instituted or are pending or, to the best knowledge … or sale in any jurisdiction, or of the initiation or threatening of any proceeding for any such purpose; and it will promptly use its commercially
S-3
EX-4.5
2pifvycl13zexda7kyw
28 Feb 24
Shelf registration
7:49pm
S-3
x7h4y 393e44
28 Feb 24
Shelf registration
7:49pm
S-3
EX-4.9
2ck531x
28 Feb 24
Shelf registration
7:49pm
S-3
EX-4.7
nykmnxim2e7losrbmdl
28 Feb 24
Shelf registration
7:49pm
S-3
EX-4.8
pe8eqqgx1iz7xesquz
28 Feb 24
Shelf registration
7:49pm
S-8
rhj7t2
28 Feb 24
Registration of securities for employees
7:40pm
S-8
umobi7pr
28 Feb 24
Registration of securities for employees
7:40pm